Cite
HARVARD Citation
Strand, V. et al. (2015). Effects of tofacitinib monotherapy on patient-reported outcomes in a randomized phase 3 study of patients with active rheumatoid arthritis and inadequate responses to DMARDs. Arthritis research & therapy. 17 (1), pp. 1-12. [Online].